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Statistical Studies in
Genetic Toxicology: A Perspective from the
U.S. National Toxicology Program
by Barry H. Margolin*
This paper surveys recent, as yet unpublished, statistical studies arising from research in genetic toxi-
cology within the U.S. National Toxicology Program (NTP). These studies all involve analyses of data
from Ames Salmonella/microsome mutagenicity tests, but the statistical methodologies are broadly ap-
plicable. Three issues are addressed: First, what is a tenable sampling model for Ames test data, and how
does one best test the adequacy of the Poisson sampling assumption? Second, given that nonmonotone
dose-response curves are fairly common in the Salmonella assay, what new statistical techniques or
modifications of existing ones seem appropriate to accommodate to this reality? Finally, an intriguing
question: How can the extensive NTP Ames test data base be used to assess the characteristics of any
mutagen-nonmutagen decision rule? The last issue is illustrated with the commonly used "two-times
background" rule.
Introduction
During the last decade the science of genetic toxi-
cology has experienced dramatic growth in its volume
ofexperimentation, its variety of assays, and the level
ofpublic awareness ofit. Evenlaymen arelikely to have
heard ofsome ofthe testsinthisfield or seen newspaper
accounts of results from one. This growth, in all its
dimensions, is attributable to the ability of these test
systems to detect, rapidly and relatively inexpensively,
environmental agents that are genotoxic; these agents
are thought to be implicated in such diverse human
health problems as cancer, aging, and birth defects (1).
It is reputed that over 2000 laboratories worldwide, in
industry, academia, andgovernment, currentlyperform
the Ames Salmonella/microsome test (2), the best
known and most widely employed of the short-term
tests for genetic toxicity. In many parts of the indus-
trialized world, regulatory decisions regarding the reg-
istration of pesticides or pharmaceuticals are based in
part on results from tests for genetic toxicity. In some
countries, such as Japan and the United States, these
tests are used in national programs to screen agents
already in the environment. It is worth remembering,
however, that this area ofscientific research is far from
mature; much remains to be achieved in terms of un-
derstandingthepreciseimplicationsofresultsfromsuch
tests for the assessment of risks to human health.
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To date, man-made industrial agents have been the
primary focus ofresearch interest in this area; there is,
however, anincreasing emphasis on naturally occurring
potential sources of genetic toxicity, such as common
dietary components. The term "genetic toxicity" is ap-
plied to the induction of genetic damage by any agent,
whether the damage be DNA point mutations at a par-
ticular locus, induction ofDNArepair, bindingto DNA,
orchromosomal aberrations, such asfragments or aneu-
ploidy. The chronic rodent carcinogenicity bioassay,
technically speaking, is not a test for genetic toxicity
because tumor development has not yet been demon-
strated to result directly from genetic damage. The so-
matic-mutation theory of cancer (3), however, is seem-
ingly reinforced weekly by new experimental findings.
Unlike the chronic rodent carcinogenicity bioassay,
for which there is a rich statistical literature, the tests
for genetic toxicity have only recently begun to attract
the attention of research statisticians; witness the
dearth of published papers containing new statistical
methodology motivated wholly or in part by problems
in genetic toxicology. Two exceptions are the works by
Collings, Margolin and Oehlert (4) on the analysis of
binomial data and by Tarone (5) on the use ofhistorical
control data. Although five years ago Hollstein et al.
(6), in anexcellentreviewofshort-termtests forgenetic
toxicity, could cite over 100 assays that had at least a
modicum of representation in the published literature,
the U.S. NationalToxicology Program (NTP) has fewer
than 20 assays in use, undergoing validation or in de-B. H. MARGOLIN
FIGURE 1. NTP tests for genetic toxicity in use, undergoing vali-
dation, or in development: germ cell targets. Listing courtesy R.
Tennant, NTP.
velopment. Figures 1 and 2 present these assays, sep-
arated astowhetherthe target used to probe an agent's
ability to induce genetic damage is a somatic or a germ
cell. Fewer than halfa dozen ofthese assays have been
studied carefully by statisticians, and fewer still have
methods of statistical analysis that are generally ac-
cepted.
The NTP statistical effort in the area ofgenetic tox-
icology has emphasized the development of objective
analyses of individual test results, methods for mean-
ingful assay validation regarding operating character-
istics, and large data bases, which can be exploited for
a variety ofpurposes, such as devising screening strat-
egies, measuring interlaboratory and interassay con-
cordance, and attempting to ascertain the degree of
predictivity of short-term tests for the chronic rodent
carcinogenicity bioassay.
This paper surveys the methodological components
ofa series ofstatistical projects, largely unpublished as
ofthis date, that were conducted under the direction of
the author in response to perceived needs in genetic
toxicology within the NTP. The principal issues ad-
dressed are: tenable sampling models and goodness of
fit; nonmonotone dose-response relationships and tests
of significance; and external validation of tests of hy-
pothesis when there is sufficient replication. All three
issues will be illustrated with the Ames test, but their
importance transcends this one assay.
Tenable Sampling Models and
Goodness of Fit
The development of a parametric statistical analysis
for data arising from short-term tests is best achieved
after scrutiny ofa variety ofdata, preferably generated
by different technicians and at least two laboratories.
One main component in the developmental process is
the creation of a tenable sampling model. Significant
departures of reality from assumption with regard to
the sampling distribution can impact substantially on
false positive and false negative rates, and on the effi-
ciency of estimators (7,8).
For short-term tests, the response of interest is fre-
quently a count, which may be bounded by definition or
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FIGURE 2. NTP tests for genetic toxicity in use, undergoing validation, or in development: somatic cell targets. Listing courtesy R. Tennant,
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not. For the Ames Salmonella/microsome test the re-
sponse is unbounded, being the number of visible bac-
terial colonies perplate after plating and incubation of
approximately 10 histidine-dependent bacteria, to-
gether with minimal medium and a dose of test com-
pound. All pipettings included in the protocol presum-
ably contribute stochastic variability.
Early authors discussing analyses of Ames test data
assumed Poisson sampling without producing any em-
pirical supporting evidence. From a theoretical stand-
point, the usual Poisson assumptions seem credible for
a given plate, but to extrapolate from one plate and
claim that a set of plate counts behaves like a random
sample from a Poisson distribution requires an addi-
tional assumption of homogeneity of environments
across plates. In some laboratories that condition may
obtain, but the key point is that this issue is open to
empirical study. The concept of uniformity trials (9)
from agricultural research deserves renewed consid-
eration by experimenters and statisticians; it suggests
the desirability of running assays early in their devel-
opment as one would to test a compound for genetic
toxicity, butwithnotestcompound added. Ideally, data
from such negative or solvent control trials can then
support or refute a particular sampling model, and can
be used to assess the possibility of hidden components
ofvariability.
Margolin et al. (8) reported results from 20 replicated
controlplates forAmestests conducted by each ofthree
laboratories. If Y1, . . ., Yn represent the control plate
counts observed by a laboratory on a given day, and if
Ydenotes their mean, then a standard test ofthe Pois-
son sampling assumption is based on the statistic
n
T (=Y - 1 )2/Y
When the data are a random sample from a Poisson
distribution, the statistic T is well approximated by a
chi-square random variable with n - 1 degrees of free-
dom. Using this fact, Margolin et al. (8) demonstrated
that the Poisson model is inadequate to describe Ames
test data; sample variance to mean ratios of4 or larger
were reported by them. In place of the Poisson, those
authors adopted a negative binomial sampling model,
whichtheymotivated as a stochastic mixture ofPoisson
distributions created by pipetting errors. Additional
evidence, both empirical and theoretical, in support of
the negative binomial (NB) model for Ames test data
is given by Collings and Margolin (10), who employed
the following form ofthe negative binomial distribution:
P{y = Y} =
R(y + c-1) cm ( 1yc-
I
y!F(c- ) 1 + cmJ 1 + cmJ
Eq. (2) obtains. Here m is the mean of Y and the limit
ofEq. (2) as c -- 0 is the Poisson distribution with mean
m. Thus, Eq. (2) extends naturally to incorporate the
Poisson distribution at c = 0. With this formulation,
one can speak of the distribution of the maximum li-
kelihood estimate (MLE) for c, which now has finite
moments of all positive orders (11). Contrast this with
the more common parametrization in terms ofk = c6-1,
where the MLE of k does not possess a proper distri-
bution (12).
Although control trials are highly useful, they are
rarely available. In general, even a good-sized random
sample of control plates is hard to come by. For ex-
ample, the data of Margolin et al. (8,10) are unique in
the literature on the Ames test.
For the general short-term test in which unbounded
count data are observed, the test results that would be
available for assessing the goodness offit ofthe Poisson
assumption are from experiments with varying doses
of true test compounds. These data are not identically
distributed, but rather have a one-way layout structure
indexed by dose. An extension to the one-way layout
of the goodness of fit test for Poisson sampling based
on Eq. (1) is studied by Collings and Margolin (10), who
obtain the following result.
THEOREM: If Yij, j = 1,...,n,z = 1,...n,r, are
independent and Yij is distributed NB (mi,c), then the
locally most powerful unbiased test ofHo: c = 0 (Pois-
son) versus H1: c > 0 (overdispersion) is conditional on
ni
aYi+ lrYijgv lueso
and rejects Ho for large values of
r ni
TC= (Yi - Y-+)/Y++ z=1 j=1 (3)
where
r ni r
Y++= E nk
The null sampling distribution of Tc and the power of
the test based upon it were also studied (10).
The theorem above generalizes a result obtained by
Potthoff and Whittinghill (13) for the case of the good-
ness-of-fit test for a Poisson random sample based upon
Eq. (1). A test statistic competitive to that in Eq. (3)
is to aggregate the value of Eq. (1) obtained for each
group separately, i.e.,
(2)
for y = 0, 1, 2, ..., 0 < m <x, and 0 < c < o. As a
shorthand, Y will be said to be distributed NB (m,c) if
r Ii
Sc = E (Yit- Yi+-)21Y+
I=1 j=1 (4)
and reference a chi-square distribution with (Xni) - r
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degrees of freedom. Collings and Margolin (10) prove
that if ni/inj
-- pi, a constant for each i = 1,. .., r,
such that 0 < pi < 1 and lp, = 1, then the Pitman
asymptotic relative efficiency ofSc to Tc is given by
ec = (2mipifI mi2pi (5)
Moreover
(min pi)
- ec 1
i
with equality obtaining on the right if and only if the
{mi} are all equal. Loosely speaking, the gain in sensi-
tivity ofTc overSc increases as the {mi} become more
disparate. Those authors also discuss goodness of fit
testing for the Poisson sampling assumption when the
data are such that Yi is distributed NB (mi,c), with mi
= im for i a known positive constant, i = 1,..., n;
they obtain atest forthisregression-through-the-origin
case that is suitable when there is reason to believe the
linearity, and when the {1Bi are quite disparate, as in
dosing studies with doses spaced logarithmically.
Nonmonotone Dose-Response and
Tests of Significance
Were the possibility of hyper-Poisson sampling var-
iability for Ames test datatheir only distinguishing fea-
ture, one could readily modify inference procedures in-
tended for Poisson data so that these procedures were
appropriate fornegative binomial data, thereby accom-
modatingthe overdispersion. Toillustrate, acommonly
used procedure to test a quantitative factor d, such as
dose, for its effect on Poisson means is to compute the
Cochran-Armitage test (14,15) for trend in the means.
If for each i, Xi is distributed as a Poisson random
variable with mean Xi and this observation is associated
with a level di of a quantitative factor, then the trend
test ofHo: Xi = X for all i, versus H1: Xi ordered by di,
is based on the statistic
n ~ n -11/2
Z = ; Xi(di - d)lsx (dj - dh)2 (6)
where sx = X = IXi/n and d = Yd,in. Z in Eq. (6)
can easily be seen to be the regression coefficient forX
regressed on d, normalized by its estimated standard
deviation. UnderHo, Z is distributed approximately as
a standard normal random variable. Tarone (5) has
shownthat the testbaseduponEq. (6) isasymptotically
locally optimal against any smooth monotone function
expressing X in terms ofd.
The modification ofthe Cochran-Armitage trend test
needed to permit its use for negative binomial data is
to define sx2 = X(1 +cX), where c is the MLE of c in
Eq. (2) when the data are considered as a random sam-
ple (HO). Again, the reference distribution for Z is the
standard normal. The Appendix contains a demonstra-
tionparallelingthatofTarone (5), whichestablishesthat
the test for trend among negative binomial means is
asymptotically locally optimal against any smooth mon-
otone function that expresses m in terms ofd. As Coll-
ings and Margolin (10) note, the negative binomial dis-
tribution in Eq. (2) can be extended to include the
binomial as well as the Poisson distribution. The Ap-
pendix then contains a proof that holds for all three
models.
Table 1 presents results from a small Monte Carlo
study ofthe size ofthe one-tailed test for trend in neg-
ative binomial means. To mimic typical experimenta-
tion, the Monte Carlo included six dose groups, with
eitherthree orfive replicate observations perdose. The
dosing was either linear (specified by d = 0, 1, . . ., 5)
orlogarithmic (specified by d = 0, 1, 10,. .., 104). Note
that these specifications entail no loss in generality be-
cause Eq. (6) is invariant to scale transformations of
dose. The values for m were set at 15 and 150, whereas
c was either 0 (Poisson) or 3/m (highly overdispersed).
Each of the 1000 data sets randomly generated for a
given set of conditions was analyzed two ways, once
with the true c used in s,, in Eq. (6) and once with the
MLE of c, as would be the case with real data. The
results indicate that the size of the trend test is well
approximated by the standard normal tail area whether
c is known or estimated from the data.
A more interesting characteristic of Ames test data
thatseparates themfrommostotherdoseresponse data
treated in the statistics literature is that the dose-re-
sponse for Ames test data is frequently not monotone
(8). There are other in vitro assays for genetic toxicity
that exhibit similar behavior, e.g., the fluctuation test
(4) and the mouse lymphoma assay (personal commu-
nication fromW. Caspary, NTP). The common decrease
in mean response at high doses, sometimes to levels
below that for the control, is usually attributed to tox-
icitythat prevents anexperimentalunitfrom exhibiting
phenotypic evidence ofmutagenicity. Decreases in the
mean response at high doses, especially to or below
control levels, impact heavily on the power of trend
tests (4), which place their greatest weight on the re-
sponses to the control and maximum dose.
Three published significance tests for various short-
term tests attempt to cope with a nonmonotone dose
response. First, Collings et al. (4) proposed the use of
an isotonic test for fluctuation test data; this test, while
not tailored to the situation under discussion, exhibits
a greater degree of power robustness against down-
turns than does the binomial trend test. Second, Bern-
stein et al. (16) proposed a recursive analysis for Ames
test data in which the response at highest dose is sub-
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Table 1. A Monte Carlo study ofthe true size of a one-tailed test for trend in negative binomial means (1000 replications).
Treatment of c in the analysis
True c used c estimated from data
m c le Scaleb 0.100C 0.050 0.025 0.010 0.100 0.050 00.025 0.010
15 0 3 LIN 0.090 0.041 0.012 0.007 0.076 0.029 0.009 0.002
15 0 3 LOG 0.089 0.057 0.026 0.012 0.084 0.045 0.016 0.004
15 0 5 LIN 0.082 0.044 0.016 0.006 0.074 0.034 0.010 0.005
15 0 5 LOG 0.088 0.040 0.019 0.010 0.081 0.033 0.015 0.008
15 0.2 3 LIN 0.088 0.038 0.012 0.005 0.090 0.041 0.013 0.005
15 0.2 3 LOG 0.100 0.059 0.035 0.015 0.113 0.064 0.034 0.011
15 0.2 5 LIN 0.084 0.039 0.022 0.005 0.089 0.043 0.017 0.006
15 0.2 5 LOG 0.092 0.045 0.026 0.014 0.096 0.050 0.028 0.010
150 0 3 LIN 0.109 0.056 0.029 0.009 0.095 0.039 0.018 0.006
150 0 3 LOG 0.112 0.059 0.029 0.010 0.094 0.048 0.018 0.006
150 0 5 LIN 0.103 0.061 0.029 0.012 0.094 0.048 0.022 0.008
150 0 5 LOG 0.108 0.057 0.030 0.007 0.096 0.040 0.018 0.004
150 0.02 3 LIN 0.102 0.052 0.021
150 0.02 3 LOG 0.113 0.061 0.03
150 0.02 5 LIN 0.104 0.058 0.03:
150 0.02 5 LOG 0.111 0.060 0.03
ar is the number of replicates per dose at each of six doses.
bFor LIN, the doses were 0, 1, 2, 3, 4, and 5; for LOG, the doses we]
'Nominal size.
jected to a pretest for downward departure from line-
arity. Ifthe pretest supports such adownturn, then the
highest dose is excluded from the analysis and the next
highest dose is similarly scrutinized. When this "point-
rejection" procedure terminates, the remaining doses
are subjected to a trend test modified for unequal var-
iances. Finally, Margolin et al. (8) developed mechan-
istic biomathematical models that reflect a somewhat
simplified view of the underlying biology of an Ames
test. They proposed a test of significance based on the
MLE of a parameter in their model that represents a
mutagenic index. The last two analyses are clearly in
need of further study to understand better their oper-
atingcharacteristics. Workonthe latteris nearing com-
pletion and will be reported elsewhere.
The use of nonparametric procedures, especially
Jonckheere's test (17), has beenadvocated foranalyzing
data from short-term tests for genetic toxicity (18,19).
Simpson and Margolin (unpublished manuscript) have
shown that nonparametric tests that are tailored to de-
tect ordered alternatives, such as Jonckheere's, can
have their power functions substantially depressed by
a downturn in the underlying dose response function.
Consequently, they devised a recursive strategy that
excludes data obtained at the highest dose if there is
evidence of a substantial downturn in response at that
dose, i.e., a departure from monotonicity.
This check for a downturn is performed recursively
with a Wilcoxon test, and when it terminates, the re-
maining doses are subjected to Jonckheere's test. The
key consideration in doing this analysis recursively is
to retain control of the size of the test. Simpson and
Margolin present both empirical and analytic evidence
for proper size behavior of their test. They also show
that their procedure is consistent for the cases of in-
6 0.011 0.116 0.050 0.022 0.010
3 0.013 0.117 0.059 0.030 0.013
2 0.014 0.111 0.056 0.029 0.011
,1 0.008 0.108 0.059 0.028 0.007
re 0, 1, 10, 100, 1000, and 10000.
terestandoffers substantialimprovementinpowerover
Jonckheere's test when there is a sizeable downturn in
dose response at high doses. This gain is achieved at a
cost of a modest loss of power when the underlying
response is, in fact, monotone in dose.
External Validation of Tests of
Hypothesis
One further important way in which the Ames Sal-
monella assay is unusual is in its sheer volume ofusage;
because the assay is fast and relatively inexpensive, it
lends itselfnicely to screening efforts. Since its creation
in 1978, the NTP has had as one of its broad goals the
extensive screening of environmental agents for evi-
dence of genetic toxicity. To date, the data collected
have come overwhelmingly from Ames tests on four
strains of Salmonella typhimurium (TA98, TA100,
TA1535, TA1537) tested separately at each of three
levels of metabolic activation: rat liver, hamster liver,
or none. The two mammalian liver (S9) preparations
represent an attempt to recreate in vitro the metabolic
processes that occur in humans. It is well known that
apparentlyinnocuouschemicals canbeconverted invivo
into noxious metabolites, so the use of an S9 activation
attempts to provide for this possibility.
Chemicals are nominated in many different ways for
NTP testing. If the scientific interest or evidence for
concern is sufficient tojustify the experimentation, the
selected chemical proceeds through a 12 strain-activa-
tion battery of tests. The NTP Salmonella/microsome
database currently consists ofover24,000 experiments,
where an experiment refers to a test with a particular
chemical, strain and activation in a given laboratory on
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Table 2. Frequency of replication by strain and activation
among the 941 chemicals.
Number of replicates
Strain Activation 1 2 3 4 5 6
TA100 None 72 774 70 22 1 1
Hamster 30 810 69 27 2 2
Rat 33 815 68 21 3 1
TA98 None 114 775 42 9 1 0
Hamster 80 784 62 10 3 2
Rat 76 787 61 13 2 2
TA1537 None 140 742 52 5 1 0
Hamster 121 765 47 6 2 0
Rat 122 764 47 7 1 0
TA1535 None 116 742 65 17 0 1
Hamster 99 756 73 8 4 1
Rat 104 746 74 12 3 1
one day. The standard protocol requires two replicates
of each experiment, usually two weeks apart. The em-
phasis, as in all good laboratory science, is on de-
monstrably reproducible results.
In some 20% ofthe experiments inthe NTP database,
the number ofreplicates is different from two. Table 2,
from Margolin, Kim, and Risko (unpublished manu-
script, hereafter referred to as MKR), indicates the
frequency ofreplication by strain and activation among
941 chemicals tested; zero frequencies have been sup-
pressed. Experimental loss due to contamination or ex-
treme toxicity, together with ad hoc decisions by ex-
perimenters not to take a second replicate produced the
singlets. Equally ad hoc decisions to obtain additional
replicates beyond the two required by the protocol ac-
count for the replicates numbering greater than two.
MKR report thatthe decision to proceedwith additional
replicates beyond two was apparently triggered on oc-
casion by results observed for TA100 with either rat or
hamster S9 activation. These two combinations were
viewed by the experimenters as the two combinations
with highest sensitivity to mutagens, and so clear res-
olution of these cases was frequently sought. The po-
tential bias in the results for these two combinations
suggests focusing attention on results forthe other ten.
MKR note that if a given chemical is tested in n rep-
licates of a given strain and activation, then the oper-
ating characteristics of any decision rule that assigns a
"mutagenic" or "nonmutagenic" label to the individual
experiments can be assessed by use of a finite mixture
ofbinomials model. Specifically, inthenotationofMKR,
if Y ofthe n replicates are judged positive and labeled
mutagenic by a decision rule, then the probability dis-
tribution function of Y can be written as:
f(Yi;p,Ti) = zib(Yi;ni,p) + (1 - zi) b(Yi;ni,Ti); (7)
where b(x;n,4) is the binomial probability distribution
function for x successes out of n trials with success
probability +; zi is an indicator variable with value 1 for
nonmutagenicity and 0 for mutagenicity ofchemical i in
the particular strain/activation; p is the true probability
that an experiment with anonmutagen in the particular
strain/activation will yield a result judged positive by
the decisionrule; Tiistheprobabilitythatanexperiment
with the particular strain/activation for chemical i,
given that chemical i is a mutagen in this combination,
will yield a result judged positive by the decision rule;
and, by assumption, T > p for all i that correspond to
mutagens.
MKR reason that p is presumably constant for all
nonmutagens tested with a given strain and activation,
but that T clearly depends upon a mutagen's potency
and toxicity for a given strain and activation. Never-
theless, they argue that the paucity of information re-
garding the behavior of a given chemical for a specific
strain and activation suggests as a first approximation
assumingTtobeconstantacrossallmutagensforagiven
strain and activation. Moreover, zi may be viewed as a
Bernoulli trial with pr{zi = 1} = x, where i represents
the proportion of nonmutagens among the chemicals
selected for testing. With this construct, the results of
applying a decision rule to data from M test chemicals
foraparticularstrain-activation are givenby{Yi;ni}'M=1
with attendant log-likelihood 1 specified by:
M
l = 2 log {H1b(Yi;ni,p) + (1 - HI)b(Yi;ni,)} (8)
This likelihood is for independent, but not identically
distributed data, a case little treated in the literature.
MKR prove that the model in Eq. (8) is identifiable if
and only if
max (ni) : 3
They then construct a version ofthe EM algorithm (20)
for the MLEs of (rr, p, i). Using results of Louis (21),
MKR also obtain the observed information matrix for
the parameters, and so produce estimates of the pre-
cision of the MLEs as well. MKR apply their analytic
technique to two decision rules. The first is a modified
statistical analysis based on the mechanistic models of
Margolin et al. (8), while the second is really not a rule,
but rather a set ofdecisions arrived at by a senior NTP
toxicologist upon his review of the experimental data.
In the present paper, the same technique is applied
to a decision rule that has been widely employed in
toxicology, but poorly understood. Labeled the "two-
times background" rule, this rule declares a chemical
mutagenic ifthe average response for at least one dose
oftest chemical is greater than twice the observed con-
currentcontrolmean. Thisrule, whichhasalonghistory
of application, is indifferent to the number of doses
tested, the number ofreplicates observed perdose, any
empirical measure ofvariability, and any consideration
oflevelofsignificance. The results ofapplyingthe MKR
technique to the decisions of the "two-times back-
ground" rule with regard to the NTP database are in
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Table 3. Estimates ± one standard deviation of the proportion
of mutagens among chemicals tested, the false positive
probability, and the true positive probability for the "two-times
background" rule by strain and activation.
Proportion of Probability Probability
mutagens of false of true
Strain Activation 1 - aT positive p positive T
TA100 None 0.088 ± 0.010 0.008 ± 0.003 0.911 ± 0.024
Rat 0.126 0.012 0.010 ± 0.004 0.925 ± 0.029
Hamster 0.154 ± 0.013 0.008 ± 0.003 0.863 ± 0.027
TA98 None 0.056 ± 0.011 0.020 ± 0.005 0.908 ± 0.067
Rat 0.101 ± 0.013 0.019 ± 0.005 0.833 ± 0.053
Hamster 0.095 + 0.011 0.019 ± 0.004 0.932 ± 0.030
TA1535 None 0.076 ± 0.014 0.018 ± 0.006 0.808 ± 0.069
Rat 0.212 ± 0.040 0.009 ± 0.014 0.623 ± 0.065
Hamster 0.211 ± 0.045 0.013 ± 0.016 0.637 ± 0.073
TA1537 None 0.130 0.089 0.070 ± 0.029 0.619 ±0.191
Rat 0.089 ± 0.020 0.063 ± 0.010 0.863 ± 0.082
Hamster 0.069 ± 0.016 0.067 ± 0.009 0.938 ± 0.079
Table 3. As one might well predict intuitively, this rule
is moderately conservative, yielding false positive rates
ofapproximately 0.01 for TA100 and 0.02 for TA98 and
TA1535, irrespective of activation level. For TA1537,
however, with its very low background rates, this rule
has a false-positive rate of approximately 0.07. These
estimates apply to the NTP protocol as executed by the
NTP contractual laboratories, and to no other context.
If one requires a repeated positive result for confir-
mation, then the probability ofa falsely confirmed pos-
itive is p2. For TA100, TA98, and TA1535, this prob-
ability is estimated to be 1 x 10-4 to 4 x 10-4. For the
NTP screening program, in which scientific judgment
in chemical nomination and selection produces a popu-
lation oftest chemicals highly enriched with mutagens,
decision rules with probabilities ofconfirmed false pos-
itivesonthe orderof10' aretooconservative and coun-
terproductive. The attendant loss in sensitivity to de-
tect weak mutagens is a heavy price to pay in order to
obtain a simple rule ofthumb. In many instances, mu-
tagens may not be able to achieve a doubling of back-
ground levels because of toxicity, solubility or other
limitations, yet they may well exhibit highly reprodu-
cible patterns of mutation induction. An excellent ex-
ample of this phenomenon is phenobarbital (22).
Concluding Remark
The statistical studies briefly surveyed here all had
their origins in problems that arose from genetic toxi-
cology. From this survey, one conclusion is clear: ge-
netic toxicology represents a rapidly growing area of
science that is rich with research opportunities for stat-
isticians.
Appendix
Assume that Yjis distributed NB(mj,c), that the {Y?}
are independent and that mj = H(a + P,dj) forHmono-
tone and twice differentiable, andj = 1,..., n. Without
loss of generality, assume further that Idj = 0. Then,
from Eq. (2), the log-likelihood of the data is given by
1 = , Y, InH(a + Pd1) -
(Yj + c-')lIn [1 + cH(a + 1dj)] + terms in c alone.
It then follows that
-f = H'(ot + Pdj) dj (Yj
- mj)/mj(l + cmj)
(A-1)
Straightforward computation yields the result that
E(a2llad ac) = 0 and thatE(d2lIdado3)I, = 0 = 0. Thus the
normalized score statistic to test Ho: , = 0 is given by
the ratio ofEq. (A-1) evaluated at (,B = 0, a = X, c =
c) to its asymptotic_standard deviation. The result is
Eq. (6) with se2 = X(1+ cX).
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